Quetiapine Fumarate Patent Expiration

Quetiapine Fumarate is Used for treating major depressive disorder (MDD) and schizophrenia. It was first introduced by Astrazeneca Pharmaceuticals Lp in its drug Seroquel on Sep 26, 1997. Another drug containing Quetiapine Fumarate is Seroquel Xr. 30 different companies have introduced drugs containing Quetiapine Fumarate.


Quetiapine Fumarate Patents

Given below is the list of patents protecting Quetiapine Fumarate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Seroquel Xr US5948437 Pharmaceutical compositions using thiazepine May 28, 2017

(Expired)

Astrazeneca
Seroquel Xr US5948437

(Pediatric)

Pharmaceutical compositions using thiazepine Nov 28, 2017

(Expired)

Astrazeneca



Quetiapine Fumarate Generics

Several generic applications have been filed for Quetiapine Fumarate. The first generic version for Quetiapine Fumarate was by Teva Pharmaceuticals Usa and was approved on Mar 27, 2012. And the latest generic version is by Ipca Laboratories Ltd and was approved on May 20, 2024.

Given below is the list of companies who have filed for Quetiapine Fumarate generic.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 400MG BASE tablet, extended release Prescription ORAL AB Nov 1, 2016
EQ 300MG BASE tablet, extended release Prescription ORAL AB May 9, 2017
EQ 200MG BASE tablet, extended release Prescription ORAL AB May 9, 2017
EQ 100MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 50MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 25MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 150MG BASE tablet, extended release Prescription ORAL AB May 9, 2017


2. ACTAVIS GRP PTC

Actavis Group Ptc Ehf has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Actavis Grp Ptc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 400MG BASE tablet Discontinued ORAL N/A Feb 27, 2013
EQ 25MG BASE tablet Discontinued ORAL N/A Feb 27, 2013
EQ 50MG BASE tablet Discontinued ORAL N/A Feb 27, 2013
EQ 100MG BASE tablet Discontinued ORAL N/A Feb 27, 2013
EQ 150MG BASE tablet Discontinued ORAL N/A Feb 27, 2013
EQ 200MG BASE tablet Discontinued ORAL N/A Feb 27, 2013
EQ 300MG BASE tablet Discontinued ORAL N/A Feb 27, 2013


3. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE tablet Discontinued ORAL N/A Oct 28, 2014
EQ 300MG BASE tablet Discontinued ORAL N/A Oct 28, 2014
EQ 50MG BASE tablet Discontinued ORAL N/A Oct 28, 2014
EQ 400MG BASE tablet Discontinued ORAL N/A Oct 28, 2014
EQ 100MG BASE tablet Discontinued ORAL N/A Oct 28, 2014
EQ 25MG BASE tablet Discontinued ORAL N/A Oct 28, 2014


4. ALIGNSCIENCE PHARMA

Alignscience Pharma Inc has filed for 2 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Alignscience Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE tablet, extended release Prescription ORAL AB Sep 28, 2018
EQ 200MG BASE tablet, extended release Prescription ORAL AB Sep 28, 2018


5. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE tablet Prescription ORAL AB Feb 12, 2013
EQ 25MG BASE tablet Prescription ORAL AB Feb 12, 2013
EQ 400MG BASE tablet Prescription ORAL AB Feb 12, 2013
EQ 300MG BASE tablet Prescription ORAL AB Feb 12, 2013
EQ 50MG BASE tablet Prescription ORAL AB Feb 12, 2013
EQ 200MG BASE tablet Prescription ORAL AB Feb 12, 2013
EQ 150MG BASE tablet Prescription ORAL AB Feb 12, 2013


6. AMNEAL PHARMS

Amneal Pharmaceuticals Of New York Llc has filed for 1 generic for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 400MG BASE tablet, extended release Discontinued ORAL N/A Oct 26, 2018


7. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 300MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 50MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 150MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 200MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 400MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017


8. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 50MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 100MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 150MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 200MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 300MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 400MG BASE tablet Prescription ORAL AB Mar 27, 2012


9. DR REDDYS LABS LTD

Dr Reddys Laboratories Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 50MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 100MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 150MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 200MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 300MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 400MG BASE tablet Prescription ORAL AB Mar 27, 2012


10. ENDO OPERATIONS

Endo Operations Ltd has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 400MG BASE tablet, extended release Discontinued ORAL N/A Dec 1, 2017
EQ 300MG BASE tablet, extended release Discontinued ORAL N/A Dec 1, 2017
EQ 200MG BASE tablet, extended release Discontinued ORAL N/A Dec 1, 2017
EQ 150MG BASE tablet, extended release Discontinued ORAL N/A Dec 1, 2017
EQ 50MG BASE tablet, extended release Discontinued ORAL N/A May 9, 2017


11. HETERO LABS LTD V

Hetero Labs Ltd Unit V has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE tablet Prescription ORAL AB Jun 16, 2022
EQ 50MG BASE tablet Prescription ORAL AB Jun 16, 2022
EQ 100MG BASE tablet Prescription ORAL AB Jun 16, 2022
EQ 200MG BASE tablet Prescription ORAL AB Jun 16, 2022
EQ 300MG BASE tablet Prescription ORAL AB Jun 16, 2022
EQ 400MG BASE tablet Prescription ORAL AB Jun 16, 2022


12. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 50MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 100MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 200MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 300MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 400MG BASE tablet Prescription ORAL AB Mar 27, 2012


13. INTELLIPHARMACEUTICS

Intellipharmaceutics Corp has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Intellipharmaceutics.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE tablet, extended release Prescription ORAL AB May 9, 2017
EQ 50MG BASE tablet, extended release Prescription ORAL AB May 9, 2017
EQ 150MG BASE tablet, extended release Prescription ORAL AB May 9, 2017
EQ 300MG BASE tablet, extended release Prescription ORAL AB May 9, 2017
EQ 400MG BASE tablet, extended release Prescription ORAL AB May 9, 2017


14. IPCA LABS LTD

Ipca Laboratories Ltd has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Ipca Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 300MG BASE tablet Prescription ORAL AB May 20, 2024
EQ 200MG BASE tablet Prescription ORAL AB May 20, 2024
EQ 100MG BASE tablet Prescription ORAL AB May 20, 2024
EQ 50MG BASE tablet Prescription ORAL AB May 20, 2024
EQ 25MG BASE tablet Prescription ORAL AB May 20, 2024
EQ 400MG BASE tablet Prescription ORAL AB May 20, 2024


15. JUBILANT GENERICS

Jubilant Generics Ltd has filed for 1 generic for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Jubilant Generics.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE tablet Discontinued ORAL N/A Nov 26, 2013


16. LUPIN LTD

Lupin Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 50MG BASE tablet, extended release Prescription ORAL AB May 17, 2017
EQ 100MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 200MG BASE tablet, extended release Prescription ORAL AB May 17, 2017
EQ 300MG BASE tablet, extended release Prescription ORAL AB May 17, 2017
EQ 400MG BASE tablet, extended release Prescription ORAL AB May 17, 2017
EQ 150MG BASE tablet, extended release Prescription ORAL AB May 17, 2017


17. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE tablet Prescription ORAL AB May 17, 2016
EQ 300MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 400MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 200MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 100MG BASE tablet Prescription ORAL AB May 17, 2016
EQ 50MG BASE tablet Prescription ORAL AB May 17, 2016
EQ 150MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017


18. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 1 generic for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE tablet Discontinued ORAL N/A Mar 27, 2012


19. NOVAST LABS

Novast Laboratories Ltd has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Novast Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 150MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 200MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 300MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 400MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017


20. PHARMADAX INC

Pharmadax Inc has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Pharmadax Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 400MG BASE tablet, extended release Prescription ORAL AB May 9, 2017
EQ 300MG BASE tablet, extended release Prescription ORAL AB May 9, 2017
EQ 200MG BASE tablet, extended release Prescription ORAL AB May 9, 2017
EQ 150MG BASE tablet, extended release Prescription ORAL AB May 9, 2017
EQ 50MG BASE tablet, extended release Prescription ORAL AB May 9, 2017


21. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 300MG BASE tablet Prescription ORAL AB Aug 24, 2022
EQ 200MG BASE tablet Prescription ORAL AB Aug 24, 2022
EQ 150MG BASE tablet, extended release Prescription ORAL AB Apr 26, 2022
EQ 50MG BASE tablet Prescription ORAL AB Aug 24, 2022
EQ 400MG BASE tablet, extended release Prescription ORAL AB Mar 11, 2024
EQ 25MG BASE tablet Prescription ORAL AB Aug 24, 2022
EQ 100MG BASE tablet Prescription ORAL AB Aug 24, 2022


22. RISING

Rising Pharma Holdings Inc has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 400MG BASE tablet, extended release Discontinued ORAL N/A Feb 2, 2021
EQ 300MG BASE tablet, extended release Discontinued ORAL N/A Feb 2, 2021
EQ 200MG BASE tablet, extended release Discontinued ORAL N/A Feb 2, 2021
EQ 50MG BASE tablet, extended release Discontinued ORAL N/A Feb 2, 2021
EQ 150MG BASE tablet, extended release Discontinued ORAL N/A Feb 2, 2021


23. SANDOZ

Sandoz Inc has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE tablet Prescription ORAL AB Dec 14, 2012
EQ 50MG BASE tablet Prescription ORAL AB Dec 14, 2012
EQ 100MG BASE tablet Prescription ORAL AB Dec 14, 2012
EQ 150MG BASE tablet Prescription ORAL AB Dec 14, 2012
EQ 200MG BASE tablet Prescription ORAL AB Dec 14, 2012
EQ 300MG BASE tablet Prescription ORAL AB Dec 14, 2012
EQ 400MG BASE tablet Prescription ORAL AB Dec 14, 2012


24. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 5 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 200MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 300MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 400MG BASE tablet, extended release Prescription ORAL AB Nov 29, 2017
EQ 50MG BASE tablet, extended release Prescription ORAL AB Nov 16, 2018


25. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 50MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 100MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 200MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 300MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 400MG BASE tablet Prescription ORAL AB Mar 27, 2012


26. TEVA PHARMS

Teva Pharmaceuticals Usa has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 300MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 400MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 50MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 25MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 100MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 150MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 200MG BASE tablet Prescription ORAL AB Mar 27, 2012


27. TORRENT PHARMS LTD

Torrent Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Torrent Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 300MG BASE tablet Discontinued ORAL N/A Mar 27, 2012
EQ 400MG BASE tablet Discontinued ORAL N/A Mar 27, 2012
EQ 25MG BASE tablet Discontinued ORAL N/A Mar 27, 2012
EQ 50MG BASE tablet Discontinued ORAL N/A Mar 27, 2012
EQ 100MG BASE tablet Discontinued ORAL N/A Mar 27, 2012
EQ 200MG BASE tablet Discontinued ORAL N/A Mar 27, 2012


28. UNICHEM

Unichem Laboratories Ltd has filed for 7 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Unichem.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE tablet Prescription ORAL AB Mar 8, 2016
EQ 200MG BASE tablet, extended release Prescription ORAL AB Aug 15, 2022
EQ 300MG BASE tablet, extended release Prescription ORAL AB Aug 15, 2022
EQ 400MG BASE tablet, extended release Prescription ORAL AB Aug 15, 2022
EQ 25MG BASE tablet Prescription ORAL AB Mar 8, 2016
EQ 50MG BASE tablet, extended release Prescription ORAL AB Aug 15, 2022
EQ 150MG BASE tablet, extended release Prescription ORAL AB Aug 15, 2022


29. ZENNOVA

Zennova Pharmaceuticals Chengdu Co Ltd has filed for 6 different strengths of generic version for Quetiapine Fumarate. Given below are the details of the strengths of this generic introduced by Zennova.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 50MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 100MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 200MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 300MG BASE tablet Prescription ORAL AB Mar 27, 2012
EQ 400MG BASE tablet Prescription ORAL AB Mar 27, 2012